Korean healthcare AI company Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, is to distribute its CE MDR Class IIa-certified AI tool RBfracture, designed for rapid and precise detection of bone fractures on X-ray images, under a strategic partnership agreed with Denmark-based Radiobotics, a musculoskeletal AI diagnostics provider.

When used alongside RBfracture, Lunit’s AI-powered chest X-ray screening solution Lunit INSIGHT CXR enhances the comprehensive diagnostic capabilities available to healthcare providers, offering a full spectrum of AI-assisted screening that spans lung abnormalities to bone fractures with a single X-ray.

The agreement furthermore allows Lunit to expand its diagnostic portfolio to include other X-ray diagnostic tools from Radiobotics, such as those for detecting knee osteoarthritis and hip dysplasia.

The partnership aims to strengthen both companies’ presence in the AI medical imaging market starting from EMEA.